DOI QR코드

DOI QR Code

4-Heteroaryl Phthalazin-1(2H)-one Derivatives as Potent Melanin Concentrating Hormone Receptor 1 (MCH-R1) Antagonists

  • Lim, Chae-Jo (Division of Drug Discovery Research, Korea Research Institute of Chemical Technology) ;
  • Lee, Ka-Eun (Division of Drug Discovery Research, Korea Research Institute of Chemical Technology) ;
  • Lee, Byung-Ho (Division of Drug Discovery Research, Korea Research Institute of Chemical Technology) ;
  • Oh, Kwang-Seok (Division of Drug Discovery Research, Korea Research Institute of Chemical Technology) ;
  • Yi, Kyu-Yang (Division of Drug Discovery Research, Korea Research Institute of Chemical Technology)
  • Received : 2012.03.15
  • Accepted : 2012.03.26
  • Published : 2012.07.20

Abstract

Keywords

References

  1. World Health Organization. http://www.who.int/mediacentre/factsheets/ fs311/en /index.html.
  2. Kopelman, P. G. Nature 2000, 404, 635.
  3. Pissios, P.; Maratos-Flier, E. Trends Endocrinol. Metab. 2003, 14, 243. https://doi.org/10.1016/S1043-2760(03)00079-1
  4. Shi, Y. Peptides 2004, 25, 1605. https://doi.org/10.1016/j.peptides.2004.02.023
  5. a) Chambers, J.; Ames, R. S.; Bergsma, D.; Muir, A.; Fitzgerald, L. R.; Hervieu, G.; Dytko, G. M.; Foley, J. J.; Martin, J.; Liu, W.- S.; Park, J.; Ellis, C.; Ganguly, S.; Konchar, S.; Cluderay, J.; Leslie, R.; Wilson, S.; Sarau, H. M. Nature 1999, 400, 261. https://doi.org/10.1038/22313
  6. Saito, Y.; Nothacker, H.-P.; Wang, Z.; Lin, S. H. S.; Leslie, F.; Civelli, O. Nature 1999, 400, 265. https://doi.org/10.1038/22321
  7. Rossi, M.; Beak, S. A.; Choi, S.-J.; Small, C. J.; Morgan, D. G. A.; Ghatei, M. A.; Smith, D. M.; Bloom, S. R. Brain Res. 1999, 846, 164. https://doi.org/10.1016/S0006-8993(99)02005-3
  8. Gomori, A.; Ishihara, A.; Ito, M.; Mashiko, S.; Matsushita, H.; Yumoto, M.; Ito, M.; Tanaka, T.; Tokita, S.; Moriya, M.; Iwaasa, H.; Kanatani, A. Am. J. Physiol.: Endocrinol. Metab. 2003, 284, E583.
  9. Shimada, M.; Tritos, N. A.; Lowell, B. B.; Flier, J. S.; Maratos-Flier, E. Nature 1998, 396, 670. https://doi.org/10.1038/25341
  10. Ludwig, D. S.; Tritos, N. A.; Mastaitis, J. W.; Kulkarni, R.; Kokkotou, E.; Elmquist, J.; Lowell, B.; Flier, J. S.; Maratos-Flier, E. J. Clin. Invest. 2001, 107, 379. https://doi.org/10.1172/JCI10660
  11. Sargent, B. J.; Moore, N. A. Br. J. Clin. Pharmacol. 2009, 68, 852. https://doi.org/10.1111/j.1365-2125.2009.03550.x
  12. Cooke, D.; Bloom, S. Nat. Rev. Drug Discov. 2006, 5, 919. https://doi.org/10.1038/nrd2136
  13. Johansson, A. Expert Opin. Ther. Patents 2011, 21, 905. https://doi.org/10.1517/13543776.2011.575063
  14. Jeon, M.-K.; Cheon, H. G. Curr. Top. Med. Chem. 2009, 9, 504. https://doi.org/10.2174/156802609788897826
  15. Rivera, G.; Bocanegra-Garcia, V.; Galiano, S.; Cirauqui, N.; Ceras, J.; Perez, S.; Aldana, I.; Monge, A. Curr. Med. Chem. 2008, 15, 1025. https://doi.org/10.2174/092986708784049621
  16. McBriar, M. D. Curr. Opin. Drug Disc. 2006, 9, 496.
  17. Handlon, A. L.; Zhou, H. J. Med. Chem. 2006, 49, 4017. https://doi.org/10.1021/jm058239j
  18. Mendez-Andino, J. L.; Wos, J. A. Drug Discov. Today 2007, 12, 972. https://doi.org/10.1016/j.drudis.2007.08.010
  19. Lim, C. J.; Kim, S. H.; Lee, B. H.; Oh, K.-S.; Yi, K. Y. Bioorg. Med. Chem. Lett. 2012, 22, 427. https://doi.org/10.1016/j.bmcl.2011.10.111
  20. Suh, J. H.; Yi, K. Y.; Kim, N. J.; Yoo, S.-e.; Oh, K.-S.; Cheon, H. G.; Ahn, M.; Lee, B. H.; Jung, W. H.; Rhee, S. D. WO 2008/140239 A1.
  21. Lim, C. J.; Kim, N.-J.; Lee, E. K.; Lee, B. H.; Oh, K.-S.; Yoo, S.-e.; Yi, K. Y. Bioorg. Med. Chem. Lett. 2011, 21, 2309. https://doi.org/10.1016/j.bmcl.2011.02.099
  22. Parham, W. E.; Bradsher, C. K.; Edgar, K. J. J. Org. Chem. 1981, 46, 1057. https://doi.org/10.1021/jo00319a003
  23. Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. https://doi.org/10.1021/jm00077a008
  24. Goss, J. M.; Schaus, S. E. J. Org. Chem. 2008, 73, 7651. https://doi.org/10.1021/jo801463j
  25. Lee, S.; Kim, G.-D.; Park, W.-K.; Cho, H.; Lee, B. H.; Yoo, S.-e.; Kong, J. Y. J. Pharmacol. Toxicol. Methods 2006, 53, 242. https://doi.org/10.1016/j.vascn.2005.09.001
  26. Masimirembwa, C. M.; Bredberg, U.; Andersson, T. B. Clin. Pharmacokinet. 2003, 42, 515. https://doi.org/10.2165/00003088-200342060-00002
  27. Lewis, J. D.; Bachmann, K. A. J. Pharm.Technol. 2006, 22, 22. https://doi.org/10.1177/875512250602200105
  28. Staudacher, I.; Schweizer, P.; Katus, H. A.; Thomas, D. Curr. Opin. Drug Disc. 2010, 13, 23.
  29. Zonzini, L.; Bianchi, F.; Cesari, N.; Sartori, M. Expert Opin. Drug Discov. 2010, 5, 1031. https://doi.org/10.1517/17460441.2010.509396

Cited by

  1. 2-Heteroaryl Benzimidazole Derivatives as Melanin Concentrating Hormone Receptor 1 (MCH-R1) Antagonists vol.34, pp.8, 2013, https://doi.org/10.5012/bkcs.2013.34.8.2305
  2. 4-Aminophthalazin-1(2H)-one Derivatives as Melanin Concentrating Hormone Receptor 1 (MCH-R1) Antagonists vol.34, pp.12, 2013, https://doi.org/10.5012/bkcs.2013.34.12.3851